Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
3.300
-0.011 (-0.33%)
At close: Jun 26, 2026, 4:00 PM EDT
3.260
-0.040 (-1.22%)
After-hours: Jun 26, 2026, 7:59 PM EDT
Company Description
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy.
The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients.
The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021.
Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Nuwellis, Inc.
| Country | United States |
| Founded | 1999 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 38 |
| CEO | John Erb |
Contact Details
Address: 12988 Valley View Road Eden Prairie, Minnesota 55344 United States | |
| Phone | 952 345 4200 |
| Website | nuwellis.com |
Stock Details
| Ticker Symbol | NUWE |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001506492 |
| CUSIP Number | 67113Y702 |
| ISIN Number | US67113Y7022 |
| Employer ID | 68-0533453 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| John L. Erb | Chief Executive Officer, President and Chairman |
| Neil P. Ayotte Esq. | Senior Vice President, General Counsel, Secretary and Chief Compliance Officer |
| Carisa Schultz | Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer |
| Kim Anderson | Vice President of Operations |
| David Lerner | Chief Technology Officer |
| Leah McMullen | Director of Communications |
| Betsy Riemenschneider | Vice President of Sales |
| Paul Wotta | Corporate Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 26, 2026 | PRE 14A | Other preliminary proxy statements |
| Jun 24, 2026 | 8-K | Current Report |
| Jun 18, 2026 | 8-K | Current Report |
| Jun 10, 2026 | 8-K | Current Report |
| Jun 8, 2026 | 424B4 | Prospectus |
| Jun 5, 2026 | S-1MEF | Registration adding securities to prior Form S-1 registration |
| Jun 4, 2026 | EFFECT | Notice of Effectiveness |
| Jun 4, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jun 2, 2026 | FWP | Free Writing Prospectus |
| May 29, 2026 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |